B+
Bull case
20%
Probability
Target price
$18.25
+19.0% vs current
OSPN
OneSpanANasdaq / Software & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
55%
Probability
Target price
$15.75
+2.7% vs current
B-
Bear case
25%
Probability
Target price
$11.75
-23.4% vs current
AI sentiment snapshot
Latest data as of 2026-05-29
Recent news sentiment (30D)
0.0
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+48.2
Score
AI commentary
Primary-source evidence is constructive but narrow: recurring ARR growth and the new repurchase authorization support the upside case, but profitability softened, NRR eased, and the packet does not verify a post-print price reaction or any analyst estimate changes. With low coverage, this stays a monitoring-positive setup rather than a high-conviction rerating call.
RankAlpha Sentiment Codex - 2026-05-29
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-04-30eventQ1 2026 print reinforced the recurring-revenue mixMedium impact
The Q1 2026 10-Q showed total revenue of $65.9 million, ARR of $192.1 million (+14% y/y), NRR of 105%, and Adjusted EBITDA of $21.0 million, which supports the recurring-business thesis even as profitability softened [#10-Q-2026-04-30].
2026-05-07eventNew $50 million repurchase authorization adds per-share supportMedium impact
On May 7, 2026, the board terminated the prior program and authorized repurchases of up to $50 million through May 7, 2028, giving management another capital-return lever if execution remains steady [#8-K-2026-05-11].
2026-09-30catalystBuild38 can broaden mobile-security cross-sell over timeMedium impact
The 10-Q says Build38, acquired on February 27, 2026, adds next-generation mobile application protection and SDK-based security to extend App Shielding, which could improve product depth and cross-sell optionality over the next several quarters [#10-Q-2026-04-30].
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-29 • Updated nightlySource: Internal modelMethodology